Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p

Abstract Background Osteosarcoma (OS) is a common severe illness globally. Lupeol has been reported to participate in the pathophysiologic properties of various cancers, including OS. This study aimed to explore the effects of lupeol on proliferation, invasion, and apoptosis on OS cells and the unde...

Full description

Bibliographic Details
Main Authors: Jinghua Zhong, Chunlei He, Fangtian Xu, Xianyun Xu, Lulin Liu, Mingjun Xu, Zheng Guo, Yili Wang, Jiahua Liao, Yonghong Li
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
OS
Online Access:http://link.springer.com/article/10.1186/s13018-020-01879-0